Secreted antibody is required for immunity to Plasmodium berghei

Infection and Immunity

Volumn 77, Issue 1, 2009, Pages 414-418

  Nunes, Julia K ^a   Starnbach, Michael N ^b   Wirth, Dyann F ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, PROTOZOAN; B-LYMPHOCYTES; IMMUNIZATION; IMMUNIZATION, PASSIVE; MALARIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARASITEMIA; PLASMODIUM BERGHEI; T-LYMPHOCYTES;

EID: 58449111003     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00982-08     Document Type: Article

References (48)

1. Abdel-Latif, M. S., et al. 2002. Recognition of variant rifin antigens by human antibodies induced during natural Plasmodium falciparum infections. Infect. Immun. 70:7013-7021.
2. Abdel-Latif, M. S., et al. 2003. Antibodies to Plasmodium falciparum rifin proteins are associated with rapid parasite clearance and asymptomatic infections. Infect. Immun. 71:6229-6233.
3. Amante, F. H., and M. F. Good. 1997. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice. Parasite Immunol. 19:111-126.
4. Bates, D. 2005. Fitting linear mixed models in R. R News 5:27-30.
5. Boes, M., et al. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160:4776-4787.
6. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
7. Bouharoun-Tayoun, H., and P. Druilhe. 1992. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 60:1473-1481.
8. Bouharoun-Tayoun, H., et al. 1990. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172:1633-1641.
9. Brake, D. A., C. A. Long, and W. P. Weidanz. 1988. Adoptive protection against Plasmodium chabaudi adami malaria in athymic nude mice by a cloned T cell line. J. Immunol. 140:1989-1993.
10. Cavacini, L. A., C. A. Long, and W. P. Weidanz. 1986. T-cell immunity in murine malaria: adoptive transfer of resistance to Plasmodium chabaudi adami in nude mice with splenic T cells. Infect. Immun. 52:637-643.
11. Cohen, S., I. A. McGregor, and S. Carrington. 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192:733-737.
12. Cox, H. W. 1958. The roles of time and atabrine in inducing chronic Plasmodium berghei infections of white mice. J. Immunol. 81:72-75.
13. Cox, H. W. 1957. Observations on induced chronic Plasmodium berghei infections in white mice. J. Immunol. 79:450-454.
14. del Portillo, H. A., et al. 2001. A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax. Nature 410:839-842.
15. Faraway, J. J. (ed.). 2005. Extending the linear model with R: generalized linear, mixed effects and nonparametric regression models. CRC Press, Boca Raton, FL.
16. Fernandez, V., et al. 1999. Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J. Exp. Med. 190:1393-1404.
17. Freeman, R. R., and C. R. Parish. 1981. Plasmodium yoelii: antibody and the maintenance of immunity in BALB/c mice. Exp. Parasitol. 52:18-24.
18. Garraud, O., S. Mahanty, and R. Perraut. 2003. Malaria-specific antibody subclasses in immune individuals: a key source of information for vaccine design. Trends Immunol. 24:30-35.
19. Gravely, S. M., and J. P. Kreier. 1976. Adoptive transfer of immunity to Plasmodium berghei with immune T and B lymphocytes. Infect. Immun. 14:184-190.
20. Groux, H., and J. Gysin. 1990. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res. Immunol. 141:529-542.
21. Jayawardena, A. N., et al. 1978. The immunological response of CBA mice to P. yoelii. II. The passive transfer of immunity with serum and cells. Immunology 34:157-165.
22. Jayawardena, A. N., et al. 1982. T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii. J. Immunol. 129:377-381.
23. Kitamura, D., et al. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350:423-426.
24. Kumar, S., et al. 1989. Interdependence of CD4 T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development. J. Immunol. 143:2017-2023.
25. -/- mice are agammaglobulinemic and fail to maintain B220-CD138+ plasma cells. J. Immunol. 178:2192-2203.
26. Laird, N. M., and J. H. Ware. 1982. Random-effects models for longitudinal data. Biometrics 38:963-974.
27. Lapierre, J. 1954. Plasmodium berghei in mice; appearance of a state of immunity following repeated treatments with nivaquine during relapse. Bull. Soc. Pathol. Exot. Filiales 47:380-387. (In French.)
28. Long, C. A., et al. 1994. Immunity to erythrocytic stages of malarial parasites. Am. J. Trop. Med. Hyg. 50(4 Suppl.):27-32.
29. McDonald, V., and R. S. Phillips. 1978. Plasmodium chabaudi in mice. Adoptive transfer of immunity with enriched populations of spleen T and B lymphocytes. Immunology 34:821-830.
30. Meding, S. J., and J. Langhorne. 1991. CD4+ T cells and B cells are necessary for the transfer of protective immunity to Plasmodium chabaudi chabaudi. Eur. J. Immunol. 21:1433-1438.
31. Miller, L. H., M. F. Good, and G. Milon. 1994. Malaria pathogenesis. Science 264:1878-1883.
32. Mombaerts, P., et al. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
33. Muramatsu, M., et al. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563.
34. Murphy, J. R., and M. J. Lefford. 1979. Host defenses in murine malaria: evaluation of the mechanisms of immunity to Plasmodium yoelii infection. Infect. Immun. 23:384-391.
35. Ndungu, F. M., et al. 2002. Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol. 24:77-82.
36. Newbold, C. I., et al. 1992. Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp. Parasitol. 75:281-292.
37. Petritus, P. M., and J. M. Burns, Jr. 2008. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection. J. Immunol. 180:444-453.
38. + T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infect. Immun. 59:51-58.
39. Revy, P., et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102:565-575.
40. Sabchareon, A., et al. 1991. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg. 45:297-308.
41. Schofield, L., and I. Mueller. 2006. Clinical immunity to malaria. Curr. Mol. Med. 6:205-221.
42. Snow, R. W., et al. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
43. Suss, G., et al. 1988. Roles of CD4- and CD8-bearing T lymphocytes in the immune response to the erythrocytic stages of Plasmodium chabaudi. Infect. Immun. 56:3081-3088.
44. Taylor-Robinson, A. W., et al. 1993. The role of TH1 and TH2 cells in a rodent malaria infection. Science 260:1931-1934.
45. Taylor-Robinson, A. W., and R. S. Phillips. 1994. Th1 and Th2 CD4+ T cell clones specific for Plasmodium chabaudi but not for an unrelated antigen protect against blood stage P. chabaudi infection. Eur. J. Immunol. 24:158-164.
46. Vinetz, J. M., et al. 1990. Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria. J. Immunol. 144:1069-1074.
47. von der Weid, T., N. Honarvar, and J. Langhorne.1996. Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J. Immunol. 156:2510-2516.
48. Weiss, M. L., and D. L. De Giusti. 1966. Active immunization against Plasmodium berghei malaria in mice. Am. J. Trop. Med. Hyg. 15:472-482.